| Literature DB >> 34032815 |
N Srikanth1, Rakesh Rana1, Richa Singhal1, Sophia Jameela1, Rajeshwari Singh1, Shruti Khanduri1, Arunabh Tripathi1, Sumeet Goel1, Leena Chhatre2, Ashwin Chandra2, B C S Rao1, K S Dhiman1.
Abstract
BACKGROUND: India follows a pluralistic system for strategic and focused health care delivery in which traditional systems of medicine such as Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy (AYUSH) coexist with contemporary medicine, and this system functions under the Ministry of AYUSH (MoA). The MoA developed a mobile app, called AYUSH Sanjivani, to document the trends of the use of AYUSH-based traditional and holistic measures by the public across India. Analysis of the data generated through this app can help monitor the extent of the use of AYUSH measures for maintenance of health during the COVID-19 pandemic and aid effective health promotion and communication efforts focused on targeted health care delivery during the pandemic.Entities:
Keywords: AYUSH Sanjivani app; Ayurveda; COVID-19; Siddha; Unani; homeopathy; traditional medicine
Year: 2021 PMID: 34032815 PMCID: PMC8110045 DOI: 10.2196/25703
Source DB: PubMed Journal: JMIRx Med ISSN: 2563-6316
Demographic and basic characteristics of the respondents.
| Characteristics | n (%) | |
|
| ||
|
| Yes | 616,295 (85.2) |
|
| No | 107,164 (14.8) |
|
| ||
|
| Male | 493,766 (80.1) |
|
| Female | 122,188 (19.8) |
|
| Did not wish to disclose | 341 (0.1) |
|
| ||
|
| Urban | 148,888 (24.2) |
|
| Rural | 467,407 (75.8) |
|
| ||
|
| Student | 83,281 (23.2) |
|
| Regular or salaried worker | 33,989 (9.4) |
|
| Casual worker | 30,092 (8.4) |
|
| Self-employed | 123,274 (34.3) |
|
| Unemployed | 67,230 (18.7) |
|
| Any other | 21,879 (6.1) |
aAYUSH: Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy.
bDistribution of total respondents.
cDistribution of respondents who were users of AYUSH-based measures.
dDistribution of users who responded to this question.
Trends of use and benefits obtained by respondents who were users of AYUSH measures (n=616,295).
| Characteristic | Value, n (%) | |
|
| ||
|
| Less than 15 days | 231,735 (37.6) |
|
| 15-30 days | 153,008 (24.8) |
|
| More than 30 days | 231,552 (37.6) |
|
| ||
|
| Strongly agree | 420,395 (68.2) |
|
| Moderately agree | 133,406 (21.6) |
|
| Moderately disagree | 11,309 (1.8) |
|
| Strongly disagree | 17,496 (2.8) |
|
| Neutral/can’t say | 33,689 (5.5) |
|
| ||
|
| Overall feeling of good health | 487,466 (79.1) |
|
| Helped prevent COVID-19 (respondent’s perception) | 50,721 (8.2) |
|
| Reduced symptoms while having COVID-19 | 31,057 (5.0) |
|
| Helped improve minor ailment other than COVID-19 | 47,051 (7.6) |
|
| ||
|
| Appetite | 20,618 (5.7) |
|
| Bowel movements | 42,017 (11.7) |
|
| Sleep | 13,559 (3.8) |
|
| Stamina | 26,397 (7.3) |
|
| Mental well-being | 27,009 (7.5) |
|
| Improvement in more than one of the above parameters | 98,352 (27.3) |
|
| No change | 131,833 (36.6) |
|
| ||
|
| Excellent improvement | 30,848 (8.6) |
|
| Good improvement | 144,927 (40.23) |
|
| Slight improvement | 133,046 (36.9) |
|
| No change | 18,240 (5.1) |
|
| Unknown | 32,724 (9.01) |
aAYUSH: Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy.
Comparison of COVID-19 test status, incidence, and symptomatic status among users and nonusers of AYUSH measures. Percentages are calculated based on the total for each column.
| Characteristics | Total, n (%) | Respondents who were users of AYUSHa measures, n (%) | Respondents who were nonusers of AYUSH measures, n (%) | ||
|
| .67 | ||||
|
| Tested | 27,661 (6.8) | 24,368 (6.8) | 3293 (6.8) |
|
|
| Not tested | 380,428 (93.2) | 335,469 (93.2) | 44,959 (93.2) |
|
|
| Total | 408,089 (100) | 359,837 (100) | 48,252 (100) |
|
|
| <.001 | ||||
|
| Positive | 13,320 (48.2) | 12,002 (49.3) | 1318 (40.0) |
|
|
| Negative | 14,341 (51.8) | 12,366 (50.7) | 1975 (60.0) |
|
|
| Total | 27,661 (100) | 24,368 (100) | 3293 (100) |
|
|
| <.001 | ||||
|
| Asymptomatic | 8545 (64.2) | 8100 (67.6) | 445 (33.8) |
|
|
| Symptomatic | 4775 (35.8) | 3902 (32.5) | 873 (66.2) |
|
|
| Total | 13,320 (100) | 12,002 (100) | 1318 (100) |
|
|
| <.001 | ||||
|
| In risk category | 19,757 (4.8) | 16,583 (4.6) | 3174 (6.6) |
|
|
| Not in risk category | 388,332 (95.2) | 343,254 (95.4) | 45,078 (93.4) |
|
|
| Total | 408,089 (100) | 359,837 (100) | 48,252 (100) |
|
|
| <.001 | ||||
|
| Hypertension | 11,941 (2.9) | 10,638 (3.0) | 1303 (2.7) |
|
|
| Asthma | 1089 (0.3) | 413 (0.1) | 676 (1.4) |
|
|
| Diabetes mellitus | 2772 (0.7) | 2284 (0.6) | 488 (1.0) |
|
|
| Heart disease | 1230 (0.3) | 992 (0.3) | 238 (0.5) |
|
|
| Kidney disease | 671 (0.2) | 490 (0.1) | 181 (0.4) |
|
|
| Cancer | 389 (0.1) | 234 (0.1) | 155 (0.3) |
|
|
| Presence of multiple comorbid conditions | 9266 (2.3) | 8033 (2.2) | 1233 (2.5) |
|
|
| None | 380,731 (93.3) | 336,753 (93.6) | 43,978 (91.2) |
|
aAYUSH: Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy.
bCompared using chi-square tests.
Logistic regression analysis to identify the association between the duration of use of AYUSH-based measures and the outcome of COVID-19 testing.
| Variable | COVID-19–positive (n=12,002) | COVID-19–negative (n=12,366) | |
|
| |||
|
| More than 30 days | 3901 (32.5) | 5221 (42.2) |
|
| Less than 30 days | 8101 (67.5) | 7145 (57.8) |
|
| |||
|
| Absent | 5679 (47.3) | 10131 (81.9) |
|
| Present | 6323 (52.7) | 2235 (18.1) |
|
| |||
|
| Not in a risk category | 4866 (40.5) | 10203 (82.5) |
|
| In a risk category | 7136 (59.5) | 2163 (17.5) |
aAYUSH: Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy.
bCrude odds ratio (95% CI) 1.52 (1.44-1.60). The crude odds ratio was computed through univariate logistic regression analysis by taking the outcome of the COVID-19 test (positive or negative) as the dependent variable and the duration of use of AYUSH measures as the independent variable.
cAdjusted odds ratio (95% CI) 0.90 (0.85-0.95). The adjusted odds ratio was computed through multivariate analysis adjusted for the presence of comorbidities and risk category as confounders.
Logistic regression analysis to identify the association between use of AYUSH-based measures and symptomatic status of respondents who tested positive for COVID-19.
| Variable | Symptomatic COVID-19–positive participants (n=4775) | Asymptomatic COVID-19–positive participants (n=8545) | |
|
| |||
|
| Yes | 3902 (81.7) | 8100 (94.8) |
|
| No | 873 (18.3) | 445 (5.2) |
|
| |||
|
| Absent | 1576 (33.0) | 4499 (52.6) |
|
| Present | 3199 (67.0) | 4046 (47.4) |
|
| |||
|
| Not in a risk category | 785 (16.7) | 4345 (50.8) |
|
| In a risk category | 3900 (83.3) | 4200 (49.2) |
aAYUSH: Ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homoeopathy.
b Crude odds ratio (95% CI) 4.01 (3.61-4.59). The crude odds ratio was computed through univariate logistic regression analysis by taking the symptomatic status of COVID-19–positive respondents as the dependent variable and use of AYUSH-based measures as an independent variable without adjusting for confounders.
cAdjusted odds ratio (95% CI) 3.48 (3.06-3.95). The adjusted odds ratio was computed through multivariate analysis adjusted for the presence of comorbidities and risk category as confounders.